Participants
Contact
The media put the spotlight on a paper by Eduardo Soriano published in Nature Communications and involving the participation of IRB researcher Natalia Carulla. The group demonstrates the protective capacity of reelin during the development of Alzheimer's disease in mice.
Read the news in Diario Médico (PDF in Spanish) and El Periódico (PDF in Catalan)
Related news
6 March 2014
Protein reelin rescues cognitive impairment in animal models of Alzheimer’s disease
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
